Remove patients conference-report-reuters-pharma-usa
article thumbnail

COVID-19 Pandemic Coverage

XTalks

Moderna, for one, recently reported positive results in older adults between 56 and 71, as well as those 71 years of age and older, who reportedly mounted levels of neutralizing antibodies against the SARS-CoV-2 virus after two doses of its vaccine that were comparable to those seen in younger adults. Moderna’s COVID-19 Vaccine.